Exhibit 107
Calculation of Filing Fee Tables
Form S-8
(Form Type)
Impact BioMedical Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security Type | Security Class Title | Fee Calculation Rule | Amount Registered | Proposed Maximum Offering Price Per Share | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | |||||||||||||||
| Equity | 2023 Employee, Director, and Consultant Equity Incentive Plan Common Stock, $0.001 par value per share | 457(h) | 18,992,079 shares(1)(2) | $ | 1.57 | (3) | $ | 29,817,564 | (3) | 0.0001531 | $ | 4,565.06 | ||||||||||
| Total Offering Amounts | $ | $ | 4,565.06 | |||||||||||||||||||
| Total Fee Offsets | - | - | - | |||||||||||||||||||
| Net Fee Due | $ | 4,565.06 | ||||||||||||||||||||
| (1) | Represents the maximum number of shares of common stock, par value $0.001 per share (“Common Stock”), of Impact BioMedical Inc. (the “Registrant”) issuable pursuant to the 2023 Employee, Director, and Consultant Equity Incentive Plan being registered herein. | |
| (2) | Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”) this registration statement also covers such additional shares of Common Stock, as may issue to prevent dilution from stock splits, stock dividends and similar transactions. | |
| (3) | Estimated solely for the purposes of determining the amount of the registration fee, pursuant to Rule 457(h) under the Securities Act, based upon the average high and low price of the Common Stock as reported on The NYSE American on January 23, 2025. |
